Jag.....we are already in next year. ~$6.7 million is base revenue for FY18. Question now is if that revenue comes in 4 quarters or in 1, 2 or 3 quarters. Either way that's still 20% more than 2017 without having to lift a finger. Also halfway to profitability.
Correct! That's how I interpreted the information. It looks to me like they may become commercially viable over the next couple of quarters. Pharma is the key...
News 
Market Data 
Discover 
